UNSPSC 51112010: Vandetanib

This classification denotes a tyrosine kinase inhibitor with the molecular formula C22H24BrFN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YO460OQ37K, chemically known as 4-quninazolinamine, n-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)- but generally known as vandetanib, which bears US NIH Compound Identifier 3081361. European Medicines Agency schedules Vandetanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29174.

UNSPSC 51112010 Vandetanib, a Commodity code, encompasses pharmaceutical products supplied through multistate cooperative purchasing agreements to state and local government healthcare facilities. Recent solicitations under this code reflect state and local procurement of generic pharmaceuticals and over-the-counter products distributed via established pharmaceutical wholesaler networks, with vendors required to maintain manufacturer relationships, cGMP and Drug Supply Chain Security Act compliance, and tiered pricing structures aligned with healthcare system needs.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the primary recent opportunity—a Request for Proposal titled MMCAP Generic Multi Source Pharmaceuticals and OTC Products (S1070000015802), posted January 20, 2026, with proposals due March 26, 2026. The RFP establishes multiple-award contracts effective July 1, 2026, for two-year terms, requiring vendors to supply comprehensive product lines with specific National Drug Codes through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Evaluation weightings favor price competitiveness (75 percent), with secondary criteria including fixed pricing (10 percent), price-format flexibility such as flat price or WAC-minus structures (5 percent each for administrative compliance and EDI capability), and agreement to a 3 percent administrative fee (5 percent). Participating jurisdictions span Minnesota and Oregon, with vendor insurance requirements of $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability; performance penalties range from $200 to $1,500 per violation for late reporting or missed onboarding timelines.